Profitability Metrics

Gross Margin
66.06%
Operating Margin
2.79%
Net Margin
-10.70%

Efficiency Metrics

Revenue per Expense Ratio
1.03
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
2.79%
Income Tax Rate
1,327,200,000.0%
EPS
-3.6500000000

Balance Sheet Analysis

Current Ratio
0.52
Cash Ratio
0.10
Working Capital
$-419.24M
Debt to Equity
1.21
Debt to Assets
32.93%
Equity Ratio
27.14%

Cash Flow Analysis

Operating Cash Flow Ratio
11.09%
Free Cash Flow Ratio
5.56%
CapEx to Revenue
5.53%
Dividends Paid
$76.96M
Stock Buybacks
$45.05M
Total Shareholder Returns
$122.01M
Cash Position Change
-22.29%

Key Takeaways (2024 FY)

  • Revenue declined by 7.2732808554879%, indicating potential market challenges
  • Increased dividend payments by 0.68%

Detailed Growth Metrics

Core Performance

Revenue
-7.27%
Net Income
-1,262.42%
EPS
-1,277.42%
Operating Income
-74.99%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-2.30%
Operating Cash Flow
-25.06%
Free Cash Flow
-37.86%

Balance Sheet Health

Assets
-12.33%
Debt
0.43%
Book Value per Share
-28.43%
Inventory
-14.69%

Shareholder Returns

Dividends per Share
0.68%
Shares Outstanding
-1.10%

Long Term Trends

3Y Revenue/Share
-1.80%
5Y Revenue/Share
8.31%
3Y Dividend/Share
1.83%
5Y Dividend/Share
5.75%